Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Pharmacophor

The JME can also serve as a query input tool for structure databases by allowing creation of complex substructure queries (Figure 2-130), which are automatically translated into SMARTS [22]. With the help of simple HTML-format elements the creation of 3D structure queries is also possible, as were used in the 3D pharmacophore searches in the NCI database system [129]. Creation of reac-... [Pg.144]

The Web-based graphical user interface permits a choice from numerous criteria and the performance of rapid searches. This service, based on the chemistry information toolkit CACTVS, provides complex Boolean searches. Flexible substructure searches have also been implemented. Users can conduct 3D pharmacophore queries in up to 25 conformations pre-calculated for each compound. Numerous output formats as well as 2D and 3D visuaHzation options are supplied. It is possible to export search results in various forms and with choices for data contents in the exported files, for structure sets ranging in size from a single compound to the entire database. Additional information and down-loadable files (in various formats) can be obtained from this service. [Pg.263]

The search for structural fragments (substructures) is very important in medicinal chemistry, QSAR, spectroscopy, and many other fields in the process of perception of pharmacophore, chromophore, or other -phores. [Pg.291]

D substructure search is usually known as pharmacophore searching in QSAR. Generally speaking, there are two major approaches to it topological and chemical function queries. These two techniques are based on a slighfly different philosophy and usually provide different results [31]. [Pg.314]

Application of the CCM to small sets (n < 6) of enzyme inhibitors revealed correlations between the inhibitory activity and the chirality measure of the inhibitors, calculated by Eq. (26) for the entire structure or for the substructure that interacts with the enzyme (pharmacophore) [41], This was done for arylammonium inhibitors of trypsin, Di-dopamine receptor inhibitors, and organophosphate inhibitors of trypsin, acetylcholine esterase, and butyrylcholine esterase. Because the CCM values are equal for opposite enantiomers, the method had to be applied separately to the two families of enantiomers (R- and S-enantiomers). [Pg.419]

The 3D pharmacophore search with C(5)ROL in the Biochemical Pathways database provided 13 different molecules as hits. To further limit the number of hits, the additional restriction was imposed that the hits should have only two hydrogen... [Pg.565]

Figure 10.3-25. a) Structure of diethylstilbestrol (DES) b) 3 D pharmacophore query of DES two hits were found c) estrone and d) estradiol. [Pg.565]

Flexible 3D alignment of a set of ligands binding to the same target and/or CoMFA analysis allowing the perception of a pharmacophore for this target. [Pg.605]

Metabolism is still a barrier to be overcome. Some QSAR, pharmacophore, protein, and rule-based models are available to predict substrates and inhibitors of a specific cytochrome P450 isoenzyme [47-55]. [Pg.608]

In a recent review the pharmacophore identification programs Catalyst, DISCO, and GASP have been compared [83]. [Pg.611]

There are two problems to consider when calculating 3D pharmacophores. First, unless the molecules are all completely rigid, one must take account of their conformational properties The second problem is to determine which combinations of pharmacophoric groups are common to the molecules and can be positioned in a similar orientation in space. More than one pharmacophore may be possible indeed, some algorithms can generate hundreds of possible pharmacophores, which must then be evaluated to determine which best fits the data. It is important to realise that all of these approaches to finding 3D pharmacophores assume that all of the molecules bind in a common manner to the macromolecule. [Pg.665]

A variant of distance geometry called ensemble distance geometry [Sheridan et al. 1986] can be used to simultaneously derive a set of conformations with a previously defined set of pharmacophoric groups overlaid. Ensemble distance geometry uses the same steps as... [Pg.667]

Fig. 12.10 Two ACE pharmacophores identified by the constrained systematic search [Dammkoehler et al. 1989],... Fig. 12.10 Two ACE pharmacophores identified by the constrained systematic search [Dammkoehler et al. 1989],...
Fig. 12.12 Four molecules used to derive the nicotinic pharmacophore by distance geometry and the pharmacophore obtained. Fig. 12.12 Four molecules used to derive the nicotinic pharmacophore by distance geometry and the pharmacophore obtained.
In a related way, ensemble molecular dynamics derives a pharmacophore using restrained molecular dynamics for a collection of molecules. A force field model is set up so that none of the atoms in each molecule sees the atoms in ainy other molecule. This enables the molecules to be overlaid in space. A restraint term is included in the potential, which forces the appropriate atoms or functional groups to be overlaid in space. [Pg.669]

When many pharmacophoric groups are present in the molecule it may be very difficult to identify all possible combinations of the functional groups (there may be thousands of... [Pg.669]

One limitation of clique detection is that it needs to be run repeatedly with differei reference conformations and the run-time scales with the number of conformations pt molecule. The maximum likelihood method [Bamum et al. 1996] eliminates the need for reference conformation, effectively enabling every conformation of every molecule to a< as the reference. Despite this, the algorithm scales linearly with the number of conformatior per molecule, so enabling a larger number of conformations (up to a few hundred) to b handled. In addition, the method scores each of the possible pharmacophores based upo the extent to which it fits the set of input molecules and an estimate of its rarity. It is nc required that every molecule has to be able to match every feature for the pharmacophor to be considered. [Pg.673]

This rarity value is equated with the fraction of hits that would be returned by searching large database of diverse molecules with the full pharmacophore (all K features) or thi subset (with K—1 features) as appropriate. Labelling this fraction of hits as p(x) we nov define q x) as the fraction of the M active molecules (i.e. the molecules originally suppliet as input to the procedure) which match each of the K + possible classes. The overal configuration is scored using ... [Pg.673]


See other pages where Pharmacophor is mentioned: [Pg.313]    [Pg.314]    [Pg.429]    [Pg.565]    [Pg.566]    [Pg.606]    [Pg.607]    [Pg.608]    [Pg.615]    [Pg.617]    [Pg.495]    [Pg.663]    [Pg.664]    [Pg.664]    [Pg.665]    [Pg.665]    [Pg.666]    [Pg.667]    [Pg.668]    [Pg.668]    [Pg.669]    [Pg.669]    [Pg.670]    [Pg.671]    [Pg.671]    [Pg.673]   
See also in sourсe #XX -- [ Pg.123 , Pg.124 , Pg.124 , Pg.125 ]

See also in sourсe #XX -- [ Pg.233 ]

See also in sourсe #XX -- [ Pg.555 ]

See also in sourсe #XX -- [ Pg.127 ]




SEARCH



12 - substrates pharmacophores

2D pharmacophore fingerprints

3-centre pharmacophores

3D pharmacophore

3D pharmacophore searching

3D pharmacophores

3D-pharmacophores fingerprints

4- Point pharmacophores molecular similarity methods

4- Point pharmacophores privileged

4- Point pharmacophores virtual screening

4-Point pharmacophores

ACE pharmacophore

Alcohols pharmacophore points

Alignment-free Pharmacophore Patterns A Correlation-vector Approach

Amide, pharmacophoric region

Amides pharmacophore points

Amines pharmacophore points

Analgesic pharmacophore

Analyzing Protein-Ligand Interactions Using Pharmacophore Fingerprints

Antihistamine pharmacophore

Antitarget Pharmacophore Models

Antitarget and ADME(T) Screening Using Pharmacophores

Application of Pharmacophore Fingerprints to Structure-based Design and Data Mining

Application of Pharmacophore Models in Virtual Screening

Application of pharmacophores

Applications of 3D Pharmacophore Fingerprints

Aromatic-cation pharmacophore

Automated Pharmacophore Generation Methods

Automated generation of pharmacophore

Based Subtype Pharmacophores

Benzimidazole pharmacophore

Beta blockers pharmacophore

Bioactive pharmacophore

C-Glycosides as Stable Pharmacophores

CATALYST pharmacophoric models

CC-1065/duocarmycin pharmacophore

Carbapenem as pharmacophore

Carboxylic acids pharmacophore points

Chemical Feature-based Pharmacophores

Chemoinformatics pharmacophore model

Chirality 4-point pharmacophore

Clustering pharmacophores

Combination of Pharmacophores

Compound library design pharmacophore-guided

Computational library design pharmacophores

Conformational analysis pharmacophore discovery

Conformational analysis pharmacophores

Convergent pharmacophores

Cross-Chemotype Pharmacophore Models

Cross-chemotype pharmacophore

Database transporter pharmacophore

Deriving and Using Three-dimensional Pharmacophores

Descriptor pharmacophore-based

Descriptor pharmacophores

Descriptors from a Pharmacophore Model

Direct approaches, pharmacophore

Direct approaches, pharmacophore modeling

Distance geometry pharmacophore modeling

Diversity pharmacophore-based

Docking and Pharmacophore Modelling for Virtual Screening

Docking pharmacophore

Dopamine pharmacophores

Dopamine transporter pharmacophore model

Dopamine-transporter inhibitors pharmacophore model

Drag pharmacophore

Drug design pharmacophore model

Drug design pharmacophores

Drug design/development pharmacophores

Drug pharmacophore-based

Drugs pharmacophore

Epothilone pharmacophore model

Esters pharmacophore points

Example Parallel pharmacophore-based virtual screening

Exploration on Mechanism of Paclitaxel Related to Tubulin Binding and Quest for Its Pharmacophore

FLAP 4-Point Pharmacophore Fingerprints from GRID

Feature Definitions and Pharmacophore Representation

Feature Point Pharmacophores

Feature Point Pharmacophores FEPOPS)

Feature pharmacophoric

Feature-based Pharmacophores Used by LigandScout

Finding Pharmacophore Features Using MOE

Fingerprint pharmacophoric

Fingerprints 4-point pharmacophore

Fingerprints pharmacophore

Food-related components pharmacophore model

Four-point pharmacophores

Fully automated pharmacophore discovery

Fuzzy Bipolar Pharmacophore

Fuzzy Pharmacophore Models

Fuzzy Pharmacophores SQUID

Fuzzy pharmacophore modeling

Fuzzy pharmacophore triplets

Fuzzy pharmacophores

GRID pharmacophore

Grid-based pharmacophore model

Grid-based pharmacophore model GBPM)

Guanidine pharmacophore points

Guanidines pharmacophore points

HERG pharmacophore model

HIPHOP pharmacophore model

HIV-1 IN inhibitor trifluoromethyl pharmacophore

Histone pharmacophore

Index-based topological pharmacophore

Interaction Pharmacophore Elements

Interaction Pharmacophore Elements IPEs)

Interaction pharmacophore

Interpretation pharmacophoric model

Ketones pharmacophore points

Keys, pharmacophore

Kresoxim pharmacophore

Lavendamycin pharmacophores

Lead optimization pharmacophore determination

Library design pharmacophores

Ligand libraries pharmacophore-based

Ligand pharmacophor

Ligand pharmacophore

Ligand pharmacophores

Ligand-based Pharmacophore Modeling

Ligand-based pharmacophores

Ligand-based topological pharmacophore

Linear QSAR models descriptor pharmacophores

Machine-learning of Topological Pharmacophores from Fingerprints

Mapping Chemical Space by Self-organizing Maps A Pharmacophore Road Map

Mapping pharmacophore

Maximizing pharmacophore diversity

Model pharmacophoric

Modeling of Selective Pharmacophores at the arAdrenergic Receptors

Molecular modeling pharmacophore-based ligand

Molecular modelling receptor/pharmacophore mapping

Molecular structure pharmacophores

Morphine pharmacophore

Multi-pharmacophore descriptors

Multiple pharmacophores

Multiple three-dimensional pharmacophoric

Multipoint pharmacophores

Muscarinic pharmacophore

Nanomolar Histamine H3 Receptor Antagonists by Structure- and Pharmacophore-Based VS

Neonicotinoids pharmacophore

Neuroleptic pharmacophore

Nicotine/nicotinic pharmacophore

Nicotinic Pharmacophore Models

Nicotinic pharmacophore

Open Source Tools for Pharmacophore Generation

Oriented-substituent pharmacophores

Paclitaxel/epothilone pharmacophore

Paclitaxel/epothilone pharmacophore model

Parallel pharmacophore-based virtual

Parallel pharmacophore-based virtual screening

Parallel synthesis and screening of bioactive pharmacophore libraries

Patterns Pharmacophore

Perception pharmacophore

Pharmacophor modification

Pharmacophore

Pharmacophore

Pharmacophore 3-center

Pharmacophore 3D-QSAR

Pharmacophore Building

Pharmacophore Combination Approach From Lock and Key to Passe-Partout Model

Pharmacophore Constraints Used in Docking

Pharmacophore Detection and Searching

Pharmacophore Fingerprints and Similarity Searches

Pharmacophore GRID probe

Pharmacophore Generation and Validation

Pharmacophore Identification and Pseudo-Receptor Modeling

Pharmacophore Model Generation

Pharmacophore Modelling in SCHRODINGER

Pharmacophore Models as Part of a Multi-step Screening Approach

Pharmacophore Models for Activity Profiling and Parallel Virtual Screening

Pharmacophore Models for Virtual Screening

Pharmacophore Models into Receptor Site

Pharmacophore Search Successes

Pharmacophore Subject

Pharmacophore Visualization

Pharmacophore alignment

Pharmacophore analysis

Pharmacophore and Drug Discovery

Pharmacophore and toxicophore

Pharmacophore anti-target

Pharmacophore applications

Pharmacophore chemical feature-based

Pharmacophore chiral

Pharmacophore class

Pharmacophore conformation

Pharmacophore conformational analysis

Pharmacophore constraint

Pharmacophore definition

Pharmacophore definition triplets

Pharmacophore descriptor

Pharmacophore determination

Pharmacophore determination process

Pharmacophore development

Pharmacophore discovery

Pharmacophore discovery applications

Pharmacophore discovery datasets

Pharmacophore discovery future

Pharmacophore diversity

Pharmacophore features

Pharmacophore field intensities

Pharmacophore filter

Pharmacophore five-point

Pharmacophore four-point

Pharmacophore four-point pharmacophoric feature

Pharmacophore generation

Pharmacophore hypothesis

Pharmacophore identification

Pharmacophore importance

Pharmacophore in carbapenem

Pharmacophore libraries

Pharmacophore ligand-based

Pharmacophore map

Pharmacophore mapping molecular modelling

Pharmacophore maps automated generation

Pharmacophore matrix

Pharmacophore method extensions

Pharmacophore modeling

Pharmacophore modeling software

Pharmacophore modelling

Pharmacophore models

Pharmacophore molecular descriptor

Pharmacophore molecular flexibility

Pharmacophore of 3-alkyl-5-arylimidazolidinediones

Pharmacophore perception algorithm

Pharmacophore plots

Pharmacophore point filters

Pharmacophore points

Pharmacophore potential

Pharmacophore prediction

Pharmacophore programs

Pharmacophore property

Pharmacophore protease inhibitors

Pharmacophore protein site-derived

Pharmacophore protein-based

Pharmacophore pseudo-receptor models

Pharmacophore query

Pharmacophore rings

Pharmacophore screening

Pharmacophore searches

Pharmacophore searching

Pharmacophore searching databases

Pharmacophore similarity scoring

Pharmacophore space

Pharmacophore strobilurins

Pharmacophore structure-based pharmacophores

Pharmacophore target

Pharmacophore three-point

Pharmacophore three-point pharmacophoric feature

Pharmacophore thrombin

Pharmacophore triplets topological

Pharmacophore validation

Pharmacophore virtual screening

Pharmacophore-Based Parallel Screening of Natural Products

Pharmacophore-Based VS

Pharmacophore-based design

Pharmacophore-based methods

Pharmacophore-based parallel

Pharmacophore-based parallel screening

Pharmacophore-based screening

Pharmacophore-based screening for novel histamine H3-receptor antagonists

Pharmacophore-based screening of compound libraries

Pharmacophore-derived queries

Pharmacophore-guided design

Pharmacophores

Pharmacophores

Pharmacophores 3D QSAR

Pharmacophores Families

Pharmacophores Identification

Pharmacophores Substructures

Pharmacophores analysis tools

Pharmacophores and Pharmacophore Searches

Pharmacophores and Toxicophores

Pharmacophores centre types

Pharmacophores defined

Pharmacophores definition

Pharmacophores determination

Pharmacophores discovery

Pharmacophores distance bins

Pharmacophores distance ranges

Pharmacophores features

Pharmacophores fingerprints

Pharmacophores for

Pharmacophores from Macromolecular Complexes with LigandScout

Pharmacophores mapping

Pharmacophores methods

Pharmacophores modeling

Pharmacophores molecular electrostatic potentials

Pharmacophores molecular interaction fields

Pharmacophores nature

Pharmacophores patterns

Pharmacophores published models

Pharmacophores receptor mapping

Pharmacophores representative queries

Pharmacophores searching

Pharmacophores site-based

Pharmacophores three-dimensional searching

Pharmacophores thyroid hormone

Pharmacophores using

Pharmacophores virtual screening

Pharmacophores with BCUT descriptors

Pharmacophores, carboranes

Pharmacophores, carboranes hydrophobic

Pharmacophoric

Pharmacophoric

Pharmacophoric alignment technique

Pharmacophoric atoms

Pharmacophoric conformations

Pharmacophoric descriptor

Pharmacophoric fragment

Pharmacophoric group, definition

Pharmacophoric groups

Pharmacophoric hypothesis

Pharmacophoric pattern

Pharmacophoric pattern search

Pharmacophoric pattern searching

Pharmacophoric points

Pharmacophoric triplets, structure activity

Postprocessing of Pharmacophore-Based Screening Hits

Potential pharmacophore points

Potential pharmacophoric points

Privileged pharmacophores

Probe pharmacophoric

Protein complementary pharmacophore

QSAR and Pharmacophores for Drugs Involved in hERG Blockage

QSAR studies descriptor-based pharmacophores

QSAR/pharmacophore programs

QSAR/pharmacophore programs Catalyst

Qualitative pharmacophore models

Quantitative pharmacophore

Quantitative pharmacophore models

Quantitative structure-activity descriptor pharmacophore

Receptor-Based Pharmacophore

Receptor-based design pharmacophore generation

Recognition pharmacophore

Representation, pharmacophore discovery

Scientific pharmacophore-based

Searching of Multiple Three-Dimensional Pharmacophoric Patterns

Searching with Transporter Pharmacophores

Selectivity receptor/pharmacophore mapping

Similar pharmacophores

Similarity Searching with Pharmacophore Fingerprints - Some Examples

Similarity Searching with Pharmacophore Fingerprints - Technical Issues

Similarity pharmacophore

Site pharmacophoric feature

Specific pharmacophore

Structure-based pharmacophore

Structure-based pharmacophore modeling

Structure-based pharmacophores

Study The Pharmacophore of Morphine

Substructures Pharmacophore Identification

Sulfonamides pharmacophore points

Sulfones pharmacophore points

Supermolecule-Based Subtype Pharmacophore and QSAR Models

TOPP (Triplets of Pharmacophoric Points)

Target and Antitarget Pharmacophore Modeling

The Taxol Pharmacophore

Three dimension pharmacophore

Three dimension pharmacophores

Three pharmacophores

Three-dimensional molecular database pharmacophore searching

Three-dimensional pharmacophore fingerprints

Three-dimensional pharmacophore keys

Three-dimensional pharmacophore search

Three-dimensional pharmacophores

Three-dimensional pharmacophoric patterns

Three-point pharmacophore limitation

Three-point pharmacophores

Topological Pharmacophore Pair Fingerprints

Topological fuzzy pharmacophore triplet

Topological pharmacophore

Topological pharmacophore descriptor

Topological pharmacophore methods

Topological pharmacophores

Topological pharmacophores descriptors

Topological pharmacophores from pharmacophore fingerprint

Topological pharmacophores index-based

Transporter Pharmacophores

Transporter pharmacophore

Trifluoromethyl pharmacophore

Triplet pharmacophore

Triplets of pharmacophoric points

Two-metal-binding pharmacophore

Validation of Pharmacophore Models

Virtual pharmacophore-based

Why Structure-based Pharmacophores

© 2024 chempedia.info